REG - Deltex Med Grp PLC - Issue of Equity

Deltex MedicalAnnouncement

11/04/2023 17:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230411:nRSK8795Va&default-theme=true

RNS Number : 8795V  Deltex Medical Group PLC  11 April 2023

11 April 2023

 

Deltex Medical Group plc

("Deltex Medical", the "Company" or the "Group")

 

Issue of equity to satisfy certain outstanding equity-settled non-executive
directors' fees

 

The Board of Deltex Medical (AIM: DEMG), the global leader in oesophageal
doppler monitoring, announces the issue of 9,993,805 new ordinary shares of 1p
each in the capital of the Company ("Ordinary Shares"), at an issue price of
1.1 pence per new Ordinary Share (the "Issue Price"). The Issue Price
represents the Company's closing mid-market price on 6 April 2023.

 

The new Ordinary Shares are being issued in order to satisfy certain deferred
non-executive directors' fees for the year ended 31 December 2021 ("Fee
Shares"). In previous years, the Company has settled the deferred
non-executive directors' fees of a calendar year in July of the following
year. This was last done on 16 July 2021 in respect of the fees ended 31
December 2020. The fees for the year ended 31 December 2021 were expected to
be settled on or around July 2022. However, the Company was in and has
continued to be in a closed period since that time. Following the publication
of the results for the year ended 31 December 2022, the Company is now in a
position to settle such outstanding non-executive directors' fees.

 

Further details of the new Ordinary Shares to be issued to each of the Deltex
Medical directors are set out in the table below.

 

                                                                  Resultant holding post Fee Shares
 Director        Current Ordinary Shares held  Fee Shares issued  Ordinary Shares Held  As a percentage of the enlarged share capital
 Nigel Keen      99,852,821                    3,448,351          103,301,172           14.57%
 Julian Cazalet  27,153,971                    2,181,818          29,335,789            4.14%
 Mark Wippell    11,037,875                    2,181,818          13,219,693            1.86%
 Chris Jones     4,297,291                     2,181,818          6,479,109             0.91%

 

Application for admission to trading and total voting rights

 

Application has been made for 9,993,805 new Ordinary Shares to be admitted to
trading on AIM, which is expected to take effect on or around 17 April 2023
("Admission").

 

Following Admission, the Company's issued share capital will comprise
709,057,601 Ordinary Shares. The Company does not hold any Ordinary Shares in
treasury. This figure may be used by shareholders in the Company as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct Authority's
Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

 Deltex Medical Group plc                                        01243 774 837

 Nigel Keen, Chairman                                             investorinfo@Deltexmedical.com
 Andy Mears, Chief Executive
 Natalie Wettler, Group Finance Director

 Nominated Adviser and Broker                                    020 3328 5656

Allenby Capital Limited

 Jeremy Porter / Vivek Bhardwaj (Corporate Finance)              info@allenbycapital.com
 Tony Quirke / Stefano Aquilino (Sales & Corporate Broking)

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them:

 

 1.    Details of the person discharging managerial responsibilities / person closely
       associated
 a)    Name                                                         PDMRs:

Nigel Keen      Non-Executive Director - Chairman
                                                                    Julian Cazalet  Non-Executive Director
                                                                    Mark Wippell    Non-Executive Director
                                                                    Chris Jones     Non-Executive Director

 

 2.    Reason for the Notification
 a)    Position/status                                              See 1a) above
 b)    Initial notification/Amendment                               Initial Notification
 3.    Details of the issuer, emission allowance market participant, auction
       platform, auctioneer or auction monitor
 a)    Name                                                         Deltex Medical Group Plc
 b)    LEI                                                          213800XN34P6LI8J6M39
 4.    Details of the transaction(s): section to be repeated for (i) each type of
       instrument; (ii) each type of transaction; (iii) each date; and (iv) each
       place where transactions have been conducted
 a)    Description of the Financial instrument, type of instrument  Ordinary shares of 0.1p each in Deltex Medical Group Plc

       Identification code                                          ISIN: GB0059337583
 b)    Nature of the transaction                                    Fee shares
 c)    Price(s) and volume(s)                                       Name            Price(s)  Volume(s)
                                                                    Nigel Keen      1.1p      3,448,351
                                                                    Julian Cazalet  1.1p      2,181,818
                                                                    Mark Wippell    1.1p      2,181,818
                                                                    Chris Jones     1.1p      2,181,818
 d)    Aggregated information:
       -  Aggregated volume                                         9,993,805
       -  Price                                                     1.1p
 e)    Date of the transaction                                      11 April 2023
 f)    Place of the transaction                                     Outside a trading venue

 

 

2.

Reason for the Notification

a)

Position/status

See 1a) above

b)

Initial notification/Amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor

a)

Name

Deltex Medical Group Plc

b)

LEI

213800XN34P6LI8J6M39

4.

Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.1p each in Deltex Medical Group Plc

 

Identification code

ISIN: GB0059337583

b)

Nature of the transaction

Fee shares

c)

Price(s) and volume(s)

 Name            Price(s)  Volume(s)
 Nigel Keen      1.1p      3,448,351
 Julian Cazalet  1.1p      2,181,818
 Mark Wippell    1.1p      2,181,818
 Chris Jones     1.1p      2,181,818

d)

Aggregated information:

-  Aggregated volume

9,993,805

-  Price

1.1p

e)

Date of the transaction

11 April 2023

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOESFAFMFEDSEDL